AXA Strategic Ventures invests in mini breathalyzer maker Floome
Axa Strategic Ventures made its first investment in an Italian startup. Think: Floome, a stylish sensor and mobile app that measures one’s blood alcohol concentration (BAC).
This kind of stylish.
This kind of price.
Floome enjoys 20k active users in Europe, Asia, South Africa, Australia and the US, and plans to use the funding – a total of 750 thousand euro made by ASV and Invitalia Ventures – to expand to new countries and form B2B partnerships. Bottom Line: in the interception of health and auto. Discovery, take note.
Recall 2017 deals below.